USSTOCK.TODAY
Market Closed
Log in Sign up

Siemens Healthineers to Rebrand and Transition In Vitro Diagnostics Division into Independent Organization

MedTech Dive · ·by G4L

DGX Quest Diagnostics Inc
$258.69 +0.10%
View chart & analysis →
  1. 1Siemens Healthineers will rebrand its in vitro diagnostics division and establish it as an independent organization by mid-2028.
  2. 2The company is pursuing operational process and R&D changes to achieve a 400 million euro cost reduction target for the Siemens Healthineers diagnostics division.
  3. 3Siemens Healthineers recorded a 4.2% decline in comparable revenue for its fourth-quarter diagnostics division.

So what's the key point?

Siemens Healthineers has decided to change the name of its testing division and operate it separately. While the company is working to reduce costs, recent revenue has decreased by 4.2 percent.

Source MedTech Dive · View original ↗

Related 3-line summaries

Labcorp and Quest Diagnostics Urge Passage of RESULTS Act MedTech Dive · Oct 31Quest Diagnostics Reports Revenue Growth and Raises Annual Guidance The Motley Fool +2 · Oct 23Quest Diagnostics reports patient record leak due to unauthorized system access Reuters · Oct 22
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news